Immunomodulatory agents for idiopathic pulmonary fibrosis
about
Non-steroid agents for idiopathic pulmonary fibrosisClinical trials of investigational agents for IPF: a review of a Cochrane reportAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementPulmonary fibrosis: pathogenesis, etiology and regulationFibrocytes and the pathogenesis of diffuse parenchymal lung disease.An integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesEffect of treatment guidelines on the initial management of idiopathic pulmonary fibrosisNovel therapeutic approaches for pulmonary fibrosis.Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.The molecular mechanisms of glucocorticoids-mediated neutrophil survival.Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatmentMolecular and cellular mechanisms of pulmonary fibrosis.N-methyl-D-aspartate receptor activation mediates lung fibroblast proliferation and differentiation in hyperoxia-induced chronic lung disease in newborn rats.New perspectives in the treatment of idiopathic pulmonary fibrosis.Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.Approach to acute exacerbation of idiopathic pulmonary fibrosis.The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.Idiopathic pulmonary fibrosis: pathogenesis and management.Fibrosis: Lessons from OMICS analyses of the human lung.
P2860
Q24235478-1C47E74F-BBB9-4889-82C2-F24D5384E5A1Q26823161-58C34B53-4DA1-4AB7-9F52-BA2E91AE897CQ28308246-25939A1C-F293-4330-9EB3-B4113515A700Q28388425-ACCC07F1-0900-4EC4-902E-9E32679D69D0Q30426516-DD28461D-36DC-4CAE-A838-534CC08AE469Q33766956-C2DBB885-AA25-446E-A8E1-8E5C58DA9843Q34019374-A16CD76F-BBE5-4D18-9014-13BD428DCDD5Q34903224-193DD37A-1BD8-4B80-9B34-67B1DD3EBF0BQ35561400-B5DDDC21-0561-465B-AA4B-64781B0F7F8FQ35701310-C724E6E5-069D-49D4-9FAC-09120C60D579Q35840808-94902715-6CD9-4D35-A4CB-BEAD3584A027Q36237168-840BAD8F-FADD-4B27-930F-9A938862B7FFQ37358867-3E7D4560-3CFB-4ACA-813F-FA8D4412DB2CQ37362597-A8BFEC97-16E8-4683-831D-4861BF4A5C8DQ38461691-E07BEC20-EF5A-497C-97B2-45C9BFD790A3Q41194552-ABEBECB0-99F2-4520-B645-D0717B952066Q42694416-EDDAAF50-81D6-4A84-A598-84C82E17551DQ50326794-98F6FED5-055A-4B4E-98E8-8FE0187BC25CQ51760494-D234A47B-68AB-4F95-B3CD-53E675B49CB4
P2860
Immunomodulatory agents for idiopathic pulmonary fibrosis
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunomodulatory agents for idiopathic pulmonary fibrosis
@ast
Immunomodulatory agents for idiopathic pulmonary fibrosis
@en
Immunomodulatory agents for idiopathic pulmonary fibrosis
@en-gb
Immunomodulatory agents for idiopathic pulmonary fibrosis
@nl
type
label
Immunomodulatory agents for idiopathic pulmonary fibrosis
@ast
Immunomodulatory agents for idiopathic pulmonary fibrosis
@en
Immunomodulatory agents for idiopathic pulmonary fibrosis
@en-gb
Immunomodulatory agents for idiopathic pulmonary fibrosis
@nl
prefLabel
Immunomodulatory agents for idiopathic pulmonary fibrosis
@ast
Immunomodulatory agents for idiopathic pulmonary fibrosis
@en
Immunomodulatory agents for idiopathic pulmonary fibrosis
@en-gb
Immunomodulatory agents for idiopathic pulmonary fibrosis
@nl
P2860
P3181
P1476
Immunomodulatory agents for idiopathic pulmonary fibrosis
@en
P2093
E. Haydn Walters
Huw Richard H R Davies
P2860
P3181
P356
10.1002/14651858.CD003134
P577
2003-04-22T00:00:00Z